Mitra Keluarga was established in 1989 with the opening of its first, 35-bed hospital in East Jakarta, with the vision to become a people-centered and leading edge healthcare provider in the nation.
Vision
We are commited to optimize million's quality of life by providing.
Mitra Keluarga Karyasehat MIKA
Mitra Keluarga Join Bloomberg's 2021 Gender-Equality Index
BY Jessica Sukarsa
Jakarta, 17 February, 2021 – Bloomberg today announced that PT Mitra Keluarga (PT Mitra) is the first company domiciled in Indonesia to be included in the 2021 Bloomberg Gender-Equality Index (“GEI”). This is the first time PT Mitra Karyasehat Tbk has participated and made it to the global list for reporting gender-related data.
The GEI recognizes publicly listed companies that brings transparency to gender-related practices and policies, increasing the breadth of environmental, social, governance (ESG) data available to investors. This year, the GEI comprised 380 companies across 44 countries and regions, and 11 sectors including automotive, banking, consumer services, engineering and construction, and retail, up from 325 companies in 2020. Firms on the 2021 index have a combined market capitalisation of USD14 trillion, up from USD12 trillion last year.
Peter T. Grauer, Chairman of Bloomberg said, “As we continue to grapple with the pandemic, we’ve seen companies put increased emphasis on the ‘S’ in ESG. The companies included in this year’s Gender-Equality Index are committed to providing an inclusive work environment, supporting work-life balance and flexible work arrangements to retain a talented workforce and create a competitive advantage in this changing business environment.”
Rustiyan Oen, CEO PT Mitra Keluarga Karyasehat Tbk. said, “Diversity makes us stronger and complements each other as we grow together and conquer all the challenges.”
Despite raising the threshold for inclusion in the 2021 index, a record number of companies disclosed their data, and the quality of disclosure continues to improve. This year, GEI companies had a 94% disclosure score on average. While the average disclosure score was high, the average data excellence score was 55%, making it evident there is still work that needs to be done. The data excellence score is broken down into scores across five pillars: female leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, sexual harassment policies, and pro-women brand.
Here are some key findings[1] from companies in the 2021 GEI:
- Flexible work environments: 87% provide flexible working hours and 85% offer flexible working locations, a benefit that has become more important amidst the Covid-19 pandemic.
- Closing the gap: On average, GEI members’ boards comprise 29% women and 61% have a Chief Diversity Officer or an executive with primary responsibility of diversity and inclusion. The companies have an average of 39% of women in revenue-producing roles and more than half (52%) require a gender diverse slate of candidates for management positions.
- Culture of inclusion: On average, index member companies are hiring more women than they are losing, 69% of which have a strategy for recruiting women, and 59% conduct a global gender-based compensation review. Additionally, on average, 85% of employees returning after parental leave remain with their company with 65% of companies offering on-site lactation rooms and 46% providing childcare subsidies or other financial support.
- Inclusion beyond the workplace: More than half (60%) sponsor financial education programs for women and 64% sponsor programs dedicated to educating women in STEM.
"Disclosure is an important component in the GEI as it is the first step towards accountability. The decisions companies make today can drive progress on equality for years to come. We welcome more companies in this dynamic region to participate, as GEI data gives investors a comprehensive view of how practices that support gender equality can drive increased employee engagement and productivity. This in turn brings higher market value to companies and create positive change in local communities," added Patricia Torres, Global Head of Bloomberg Sustainable Finance Solutions at Bloomberg.
[1] Data provided for 2021 index is from fiscal year 2019
Source: Bloomberg
---
PT Mitra Keluarga Karyasehat Tbk at a glance
The Company built its first hospital back in 1989 and currently owns and operates 25 hospitals, sixteen of which are located in the Greater Jakarta area, five in West Java, three in Surabaya (East Java), and one in Tegal (Central Java). Normally, the hospitals are equipped with emergency rooms, outpatient clinics, inpatient wards, operating rooms, intensive care units and a pharmacy, as well as laboratory and radiology facilities. The hospitals also offer specialized services such as obstetrics, pediatrics, internal medicine, angioplasty, orthopedic surgery and neurosurgery, amongst others.
From its humble beginnings, The Company has transformed into one of Indonesia’s biggest private hospital operators by an intake of 2.6 million patients in 2020 and in terms of hospital bed capacity with 3,105 operational beds as of December 31, 2020. The Company employed around 7,382 medical and non medical staffs with around 1,342 specialists practicing in all of its hospitals by 2020.
The Company successfully listed its shares in the Indonesia Stock Exchange on March 24, 2015. With 19.78% free-float, the Company has a market capitalization of IDR 38.9 trillion as of December 31, 2020. (IDX:MIKA). Mitra Keluarga Karyasehat MIKA
Mitra Keluarga Books Record Earnings in Q4 2020
BY Jessica Sukarsa
Jakarta, March 9, 2021
PT Mitra Keluarga Karyasehat Tbk. ("Mitra Keluarga" or "the Company") has announced its financial results for the months ending December 31, 2020.
Mitra Keluarga posted FY 2020 revenue of IDR 3.42 trillion, compared to IDR 3.21 trillion over the same period in 2019; EBITDA was recorded at IDR 1.31 trillion compared to IDR 1.15 trillion in the same period last year. Mitra Keluarga successfully turned around its performance during the second half of 2020, as both revenue and EBITDA for that period booked IDR 1.98 trillion and IDR 839.6 billion, versus 1.62 trillion and IDR 560.3 billion in the second half of 2019, representing YoY growth of 22.1% and 49.9%, respectively.
Further, Mitra Keluarga booked record earnings in 4Q 2020, as Revenue and EBITDA margin reached IDR 1.1 trillion and 43.1%, which was the highest in our history. Revenue-per-inpatient-day and revenue-per-outpatient-visit for FY 2020 rose by 17.5% and 24.5% YoY, respectively, despite total patient volume only marking close to 80% of a normal level. During the second half of 2020, one third of inpatient cases were COVID-19-related, and the intensity of treatment for each COVID-19 case was considerably higher, involving more diagnostic tests and a high volume of medications for severe COVID-19 cases. In 2020 we handled a total of more than 153.300 COVID-19 cases within our hospital network. In facing the COVID-19 pandemic and responding to the huge number of cases, we implemented initiatives, including:
- COVID-19 bed capacity increased from 210 beds in the first quarter of 2020 to 1,039 beds by the fourth quarter, in both Mitra Keluarga and Kasih Group facilities.
- Set up additional in-house PCR test laboratories: as of December 31,2020, we operate ten laboratories, handling more than 2,000 PCR tests daily.
- Improved both cost efficiency and productivity, FY 2020 YoY total operating expense down by 0.1%.
- Imposed strict anti-infection protocols, which include the use of engineering controls (among others outdoor assessment and triage facilities for patients with respiratory symptoms), upgraded indoor air quality, patient and visitor screening measures, reduced healthcare personnel exposure by providing appropriate Personal Protective Equipment (PPE) along with extra nutrients & supplements. As a result, the confidence level of the healthcare personnel has significantly risen, with more than 90% of specialists having resumed their normal practice hours in 4Q 2020.
- Provided teleconsultation services, as an alternate patient entry point; as of December 31, 2020, more than 2,000 teleconsultations have been served, since its launch in April 2020.
Hospital Expansion Plan
Mitra Keluarga will continue to add more hospitals in the future, through both greenfield and brownfield expansion plans:
- Mitra Keluarga launched its newest service on January 10, 2020, related to fertility health, namely, the MBRIO Fertility Clinic, located at Mitra Keluarga Kelapa Gading Hospital; the facility is supported by experienced gynecologists and andrologists.
- Mitra Keluarga proudly announced the opening of its 26th Hospital, in East Java. Mitra Keluarga Pondok Tjandra began operation on February 22, 2021 and expected to become a key referral hospital for Covid-19 patients, as East Java is unfortunately one of the top 4 contributors to Covid-19 cases nationally, while bed capacity is still severely limited.
- Mitra Keluarga plans to commence groundbreaking on our 27th & 28th hospitals in 1H 2021.
- M&A opportunities remain a potential of Mitra Keluarga growth strategies; currently, two hospital is in the pipeline.
FY20 Financial Performance
- Total Revenues of IDR 3.42 trillion for FY 2020, compared to IDR 3.21 trillion YoY, representing an increase of 6.7%.
- Total Outpatient Visits of 2.1 million for FY 2020, compared to 2.7 million YoY, a 23.0% decline.
- Total Inpatient Days of 602.7 thousand for FY 2020, compared to 624.3 thousand YoY, a decrease of 3.5%.
- Revenue per Outpatient Visit of IDR 571 thousand for FY 2020, compared to IDR 459 thousand YoY, representing an increase of 5%.
- Revenue per Inpatient Day of IDR 3.72 million for FY 2020, compared to IDR 3.17 million YoY, for an increase of 17.5%.
- Bed Occupancy Ratio of 53.0% for FY 2020, compared to 59.5% YoY, a decrease of 6.4%. There were an additional 229 operational beds in 2020. Representing an increase of 8.0%
- Gross Profit of IDR 1.69 trillion for FY 2020, compared to IDR 1.53 trillion YoY, an increase of 10.3%.
- Gross Profit Margin of 49.5% for FY 2020, compared to 47.9 % YoY, an increase of 1.6%.
- Operating Expenses of IDR 648.7 billion for FY 2020, compared to IDR 649.4 billion YoY, a decrease of 0.1%.
- EBITDA of IDR 1.31 trillion for FY 2020 compared to IDR 1.15 trillion YoY, an increase of 13.8%.
- EBITDA Margin of 38.2% for FY 2020 compared to 35.8% YoY, an increase of 2.4%.
- Net Profit of IDR 923.5 billion for FY 2020, compared to IDR 791.4 billion YoY, increased by 16.7%. The Company has a cash position of IDR 2.3 trillion as of December 31, 2020.
PT Mitra Keluarga Karyasehat Tbk at a glance
The Company built its first hospital back in 1989, and currently owns and operates 25 hospitals, sixteen of which are located in the Greater Jakarta area; there are five in West Java, three in Surabaya (East Java), and one in Tegal (Central Java). The majority of hospitals are equipped with emergency rooms, outpatient clinics, inpatient wards, operating rooms, intensive care units and a pharmacy, as well as laboratory and radiology facilities. They also offer specialized services, such as obstetrics, pediatrics, internal medicine, angioplasty, orthopedic surgery and neurosurgery, among others.
From its humble beginnings, the Company has transformed itself into one of Indonesia’s biggest private hospital operators, with an intake of 2.2 million patients in 2020; in terms of hospital bed capacity, there are 3,105 operational beds as of December 31, 2020. The Company employed approximately 7,382 medical and non-medical staff, with some 1,345 specialists practicing in all of its hospitals by end-2020.
The Company successfully listed its shares in the Indonesia Stock Exchange on March 24, 2015. With 19.78% free-float, the Company has a market capitalization of IDR 38.9 trillion as of December 31, 2020. (IDX:MIKA). Mitra Keluarga Karyasehat MIKA
Mitra Keluarga Posted Robust 37.6% YoY Revenue Growth in 1Q 2021
BY Jessica Sukarsa
Jakarta, April 23, 2021
PT Mitra Keluarga Karyasehat Tbk. ("Mitra Keluarga" or "Company") has announced financial results for the quarter ending March 31, 2021.
Mitra Keluarga posted robust revenue growth of 37.6% YoY in 1Q 2021, mainly driven by COVID-19 cases, which command higher intensity. COVID-19 reached its peak level in mid-February 2021 and continues to subside thereafter. Total COVID-19-related testing (PCR and Rapid Test) during the 1Q 2021 increased by 8.9% QoQ compared to 4Q 2020. Volume for Non-COVID-19 inpatient days also increased, up 5.6% QoQ compared to 4Q 2020.
As a result, during the first quarter of 2021, Mitra Keluarga recorded revenues of IDR 1.2 trillion compared to IDR 874.7 billion over the same period in the previous year. EBITDA was booked at IDR 527.2 billion, or 66.0% YoY higher, reflecting an EBITDA margin of 43.8%. The continued gross profit margin expansion (up from 47.5% in 1Q 2020 to 53.9% in 1Q 2021) and growth operating expenses of 17.8% were the main contributors to EBITDA growth during the first quarter of 2021.
On February 22, 2021, Mitra Keluarga announced the opening of its 26th Hospital, Mitra Keluarga Pondok Tjandra, located in Surabaya, East Java. As of March 31, 2021, this hospital has a total bed capacity for of 150 beds and initially operating 36 fully-operational beds. The opening of this new hospital will certainly strengthen Mitra Keluarga’s business portfolio and social profile in East Java.
Hospital Expansion Plan
Mitra Keluarga will continue to add more hospitals in the future, through both greenfield and brownfield expansion plans:
- Mitra Keluarga launched its newest service on January 11, 2021, related to fertility health, namely, the MBRIO Fertility Clinic, located at Mitra Keluarga Kelapa Gading Hospital; the facility is supported by experienced gynecologists and andrologists.
- Mitra Keluarga proudly announced the opening of its 26th Hospital, in East Java. Mitra Keluarga Pondok Tjandra began operation on February 22, 2021.
- Mitra Keluarga plans to commence groundbreaking on its 27th & 28th hospitals in 1H 2021.
- M&A opportunities remain potential of Mitra Keluarga growth strategies; two hospitals are currently in the pipeline.
1Q21 Financial Performance
- Total Revenues of IDR 1.2 trillion for 1Q 2021, compared to IDR 874.7 billion YoY, representing an increase of 37.6%.
- Total Outpatient Visits of 565.8 thousand for 1Q 2021, compared to 693.4 thousand YoY, a 18.4% decline.
- Total Inpatient Days of 183.9 thousand for 1Q 2021, compared to 179.1 thousand YoY, an increase of 2.7%.
- Average Revenue per Outpatient Visit of IDR 690.7 thousand for 1Q 2021, compared to IDR 467.5 thousand YoY, representing an increase of 47.8%.
- Average Revenue per Inpatient Day of IDR 4.4 million for 1Q 2021, compared to IDR 3.1 million YoY, for an increase of 43.8%.
- Bed Occupancy Ratio of 63.4% for 1Q 2021, compared to 65.7% YoY, a decrease of 2.3%. Total Operational Beds for 1Q 2021 numbered 3,224, representing an increase of 7.6% YoY.
- Gross Profit of IDR 648.9 billion for 1Q 2021, compared to IDR 415.6 billion YoY, an increase of 56.1%.
- Gross Profit Margin of 53.9% for 1Q 2021, compared to 47.5% YoY, an increase of 6.4%.
- Operating Expenses of IDR 194.2 billion for 1Q 2021, compared to IDR 164.9 billion YoY, an increase of 17.8%.
- EBITDA of IDR 527.2 billion for 1Q 2021 compared to IDR 317.6 billion YoY, an increase of 66.0%.
- EBITDA Margin of 43.8% for 1Q 2021 compared to 36.3% YoY, an increase of 7.5%.
- Net Profit of IDR 373.7 billion for 1Q 2021, compared to IDR 220.4 billion YoY, increased by 69.6%. The Company has a cash position of IDR 2.6 trillion as of March 31, 2021.
PT Mitra Keluarga Karyasehat Tbk at a glance
The Company built its first hospital back in 1989, and currently owns and operates 26 hospitals, sixteen of which are located in the Greater Jakarta area; there are five in West Java, four in Surabaya (East Java), and one in Tegal (Central Java). The majority of hospitals are equipped with emergency rooms, outpatient clinics, inpatient wards, operating rooms, intensive care units and a pharmacy, as well as laboratory and radiology facilities. They also offer specialized services, such as obstetrics, pediatrics, internal medicine, angioplasty, orthopedic surgery and neurosurgery, among others.
From its humble beginnings, the Company has transformed itself into one of Indonesia’s biggest private hospital operators, with an intake of 2.2 million patients in 2020; in terms of hospital bed capacity, there are 3,105 operational beds as of December 31, 2020. The Company employed approximately 7,382 medical and non-medical staff, with some 1,345 specialists practicing in all of its hospitals by end-2020.
The Company successfully listed its shares in the Indonesia Stock Exchange on March 24, 2015. With 38.14% free-float, the Company has a market capitalization of IDR 38.9 trillion as of December 31, 2020. (IDX:MIKA). Mitra Keluarga Karyasehat MIKA
Head Office
Jalan Pengasinan
